Literature DB >> 23973346

Epidemiology of Group B Streptococcus in developing countries.

Atul Kumar Johri1, Hem Lata, Puja Yadav, Meenakshi Dua, Yonghong Yang, Xiaoning Xu, Akira Homma, Michèle Anne Barocchi, Matthew J Bottomley, Allan Saul, Keith P Klugman, Steven Black.   

Abstract

Group B Streptococcus (GBS) causes pneumonia, meningitis and sepsis in neonates. The current distribution pattern of GBS serotypes in developing countries such as India, China and Brazil is not clear. In order to appropriately plan for vaccination programs to address the burden of this disease in these countries, prospective population based studies are urgently needed. In our discussions, we focused on India, China and Brazil because of the membership of our workgroup, but data on other countries are also presented here. Further studies in developing countries are needed so as to better formulate appropriate public health interventions.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Group B Streptococcus; Maternal immunization; Neonatal

Mesh:

Year:  2013        PMID: 23973346     DOI: 10.1016/j.vaccine.2013.05.094

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Invasive group B streptococcal infection in infants in Shenzhen, China.

Authors:  Jiaosheng Zhang; Ruizhen Zhao; Yimei Dong; Yuejie Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Maternal immunization: opportunities for scientific advancement.

Authors:  Richard H Beigi; Kimberly B Fortner; Flor M Munoz; Jeff Roberts; Jennifer L Gordon; Htay Htay Han; Greg Glenn; Philip R Dormitzer; Xing Xing Gu; Jennifer S Read; Kathryn Edwards; Shital M Patel; Geeta K Swamy
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

3.  [Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes].

Authors:  Lindong Yang; Fang Bao; Yuanzhe Wu; Lizhou Sun
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

4.  Group B Streptococcus causes severe sepsis in term neonates: 8 years experience of a major Chinese neonatal unit.

Authors:  Ying Dong; Si-Yuan Jiang; Qi Zhou; Yun Cao
Journal:  World J Pediatr       Date:  2017-05-09       Impact factor: 2.764

Review 5.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05

6.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

7.  Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational study.

Authors:  Haiying Liu; Houlin Zeng; Weidong Wang; Qiulan Deng; Immaculada Margarit; C Daniela Rinaudo; Todd Swarthout; Marianne Cunnington; Wenjing Ji; Guozhu Geng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 8.  Genome-wide analyses of small non-coding RNAs in streptococci.

Authors:  Nadja Patenge; Roberto Pappesch; Afsaneh Khani; Bernd Kreikemeyer
Journal:  Front Genet       Date:  2015-05-20       Impact factor: 4.599

9.  Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.

Authors:  Maria del Pilar Crespo-Ortiz; Claudia Rocio Castañeda-Ramirez; Monica Recalde-Bolaños; Juan Diego Vélez-Londoño
Journal:  BMC Infect Dis       Date:  2014-08-03       Impact factor: 3.090

10.  Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China.

Authors:  Edmondo Campisi; Roberto Rosini; Wenjing Ji; Silvia Guidotti; Maricarmen Rojas-López; Guozhu Geng; Qiulian Deng; Huamin Zhong; Weidong Wang; Haiying Liu; Cassandra Nan; Immaculada Margarit; C D Rinaudo
Journal:  Front Microbiol       Date:  2016-08-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.